Signify Health Inc

SGFY

New York Stock Exchange. Currency in USD

28.52 -0.02 ( -0.07% )

Real time prices: December 19

Market Cap.
6.73B
Beta (5Y monthly)
-
Price/Earnings
-
EPS (TTM)
-0.55
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
1.26M
1y Target Est.
29.42
Day's Range
28.41
-
28.61
52 Week's Range
10.70
-
29.88

Historical Summary

Performance
EPS growth
Share Buybacks

About Signify Health Inc

Sector
Healthcare
Industry
Health Information Services
Website
https://www.signifyhealth.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
170.42M
Employees
2200
Address
4055 Valley View Lane, Dallas, TX, United States, 75244
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City. Signify Health, Inc. was founded in 2017 and is headquartered in Dallas, Texas.

Latest news

Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health
Cathie Wood Adds $7M Of This Clinical-Stage Biotech, Trims Stake In CVS-Target Signify Health

Cathie Wood-led ARK Investment Management bought over 330,000 shares of clinical-stage biotechnology company Verve Therapeutics...
By Benzinga - 8 weeks ago

Patterson Cos. (PDCO) Q2 Earnings Beat Estimates
Patterson Cos. (PDCO) Q2 Earnings Beat Estimates

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 10.53% and 3.26%, respectively, for the...
By Zacks Investment Research - 9 weeks ago

Icosavax, Inc. (ICVX) Reports Q3 Loss, Lags Revenue Estimates
Icosavax, Inc. (ICVX) Reports Q3 Loss, Lags Revenue Estimates

Icosavax, Inc. (ICVX) delivered earnings and revenue surprises of 3.51% and 100%, respectively, for the...
By Zacks Investment Research - 11 weeks ago

2 Stocks I'd Buy Right Now Without Hesitation
2 Stocks I'd Buy Right Now Without Hesitation

One's a growth stock and the other pays a dividend but both of these healthcare...
By The Motley Fool - 11 weeks ago

Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates
Fulgent Genetics, Inc. (FLGT) Beats Q3 Earnings and Revenue Estimates

Fulgent Genetics, Inc. (FLGT) delivered earnings and revenue surprises of 88.24% and 1.89%, respectively, for...
By Zacks Investment Research - 12 weeks ago

CVS: Surprisingly Fantastic Q3 Earnings
CVS: Surprisingly Fantastic Q3 Earnings

SA Contributor Daniel Jones talks CVS's surprisingly fantastic recent earnings. Cano Health deal - don't...
By Seeking Alpha - 12 weeks ago

Should You Buy CVS Health Stock Now?
Should You Buy CVS Health Stock Now?

The stock responded well to third-quarter earnings, but the company also lost a frightening $3.4...
By The Motley Fool - 13 weeks ago

Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update

ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see...
By Seeking Alpha - 15 weeks ago